These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18560121)

  • 21. Gridifying phylogeny and medical applications on the volunteer computing platform XtremWeb-CH.
    Abdennadher N; Evéquoz C; Billat C
    Stud Health Technol Inform; 2008; 138():24-33. PubMed ID: 18560105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription guidelines in OPADE: what are they, how are they used?
    de Zegher I; Milstein C; Séné B; Venot A
    Stud Health Technol Inform; 1995; 16():199-205. PubMed ID: 10163715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual objects in large scale health information systems.
    Pomares A; Roncancio C; Abásolo J
    Stud Health Technol Inform; 2008; 138():80-9. PubMed ID: 18560110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementing HISA standard in the middleware layer of our applications.
    Planinc N; Bercic B; Pikec M
    Stud Health Technol Inform; 1999; 68():55-8. PubMed ID: 10724949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Resistance screening].
    Sierra S; Lengauer T; Kaiser R
    MMW Fortschr Med; 2009 Apr; 151(18):72, 74-5. PubMed ID: 19769083
    [No Abstract]   [Full Text] [Related]  

  • 26. [Integrase inhibition].
    Bogner JR
    MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
    [No Abstract]   [Full Text] [Related]  

  • 27. Doing IT right at the University of Utah.
    Pincetl PS
    MD Comput; 1999; 16(6):37-40. PubMed ID: 10658401
    [No Abstract]   [Full Text] [Related]  

  • 28. Researchers come together to study natural HIV resistance.
    Willyard C
    Nat Med; 2009 Nov; 15(11):1233. PubMed ID: 19893537
    [No Abstract]   [Full Text] [Related]  

  • 29. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision support system supporting clinical reasoning process - an evaluation study in dementia care.
    Lindgren H
    Stud Health Technol Inform; 2008; 136():315-20. PubMed ID: 18487750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stigmatization, metabolic trouble, drug resistance: current challenges in HIV therapy].
    Mauss S; Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):28. PubMed ID: 19769068
    [No Abstract]   [Full Text] [Related]  

  • 33. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
    Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 35. Reusable services from the neuGRID project for grid-based health applications.
    Anjum A; Bloodsworth P; Habib I; Lansdale T; McClatchey R; Mehmood Y;
    Stud Health Technol Inform; 2009; 147():283-8. PubMed ID: 19593068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making large-scale telemedicine work: a computational infrastructure for telemedicine.
    von Laszewski G; Thiruvathukal GK; Foster I
    Stud Health Technol Inform; 2000; 79():195-213. PubMed ID: 11151613
    [No Abstract]   [Full Text] [Related]  

  • 37. Modeling and acquisition of drug-drug interaction knowledge.
    Mille F; Degoulet P; Jaulent MC
    Stud Health Technol Inform; 2007; 129(Pt 2):900-4. PubMed ID: 17911846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.
    Prescrire Int; 2008 Jun; 17(95):98-101. PubMed ID: 18623908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of HIV-1 in a patient population failing multiple-drug therapy.
    Hong S; Cao J; Tu YT
    Microbiol Immunol; 2009 Sep; 53(9):535-9. PubMed ID: 19703248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The next transformation in the delivery of health care.
    Kassirer JP
    N Engl J Med; 1995 Jan; 332(1):52-4. PubMed ID: 7990866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.